DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients

DENVER, Feb. 17, 2022 /PRNewswire/ — Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis patients who received an mRNA-based vaccine…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.